Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial

BACKGROUND: Raised serum uric acid (SUA) level is commonly observed in patients with type 2 diabetes mellitus (T2DM) and is associated with increased morbidity and mortality. Sodium-glucose cotransporter 2 inhibitor, a novel oral diabetic drug, might exert a potential hypouricemic effect. We evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hao, Zhaohu, Huang, Xiao, Shao, Hailin, Tian, Fengshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294165/
https://www.ncbi.nlm.nih.gov/pubmed/30587997
http://dx.doi.org/10.2147/TCRM.S186347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294165/
https://www.ncbi.nlm.nih.gov/pubmed/30587997
http://dx.doi.org/10.2147/TCRM.S186347

Ejemplares similares